Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

Apple Partnership Strengthens Unity Software's Investment Appeal: https://www.marketbeat.com/logos/articles/med_20230607080616_apple-partnership-strengthens-unity-softwares-inve.jpg
Apple Partnership Strengthens Unity Software's Investment Appeal

Unity Software (NYSE: U) saw its share price rocket higher Monday afternoon and closed the day up almost 20% after Apple (NASDAQ: AAPL) announced they are working together on the Apple Vision Pro

Apple Partnership Strengthens Unity Software's Investment Appeal: https://www.marketbeat.com/logos/articles/med_20230607080616_apple-partnership-strengthens-unity-softwares-inve.jpg
Apple Partnership Strengthens Unity Software's Investment Appeal

Unity Software (NYSE: U) saw its share price rocket higher Monday afternoon and closed the day up almost 20% after Apple (NASDAQ: AAPL) announced they are working together on the Apple Vision Pro

Apple Partnership Strengthens Unity Software's Investment Appeal: https://www.marketbeat.com/logos/articles/med_20230607080616_apple-partnership-strengthens-unity-softwares-inve.jpg
Apple Partnership Strengthens Unity Software's Investment Appeal

Unity Software (NYSE: U) saw its share price rocket higher Monday afternoon and closed the day up almost 20% after Apple (NASDAQ: AAPL) announced they are working together on the Apple Vision Pro

Sprinklr Gets Targets Raised By Analysts, Here's Why: https://www.marketbeat.com/logos/articles/med_20230607051731_sprinklr-gets-targets-raised-by-analysts-heres-why.jpg
Sprinklr Gets Targets Raised By Analysts, Here's Why

In today's market, it would seem that every stock and company with the word 'technology' entrenched in its business model is enjoying a significant rally this month; the new sentiment comes from

Sprinklr Gets Targets Raised By Analysts, Here's Why: https://www.marketbeat.com/logos/articles/med_20230607051731_sprinklr-gets-targets-raised-by-analysts-heres-why.jpg
Sprinklr Gets Targets Raised By Analysts, Here's Why

In today's market, it would seem that every stock and company with the word 'technology' entrenched in its business model is enjoying a significant rally this month; the new sentiment comes from

Sprinklr Gets Targets Raised By Analysts, Here's Why: https://www.marketbeat.com/logos/articles/med_20230607051731_sprinklr-gets-targets-raised-by-analysts-heres-why.jpg
Sprinklr Gets Targets Raised By Analysts, Here's Why

In today's market, it would seem that every stock and company with the word 'technology' entrenched in its business model is enjoying a significant rally this month; the new sentiment comes from

GeneTex Launches PD-L1 Antibody Comprehensively Validated by MS Validated Antibodies GmbH for Immunohistochemistry: https://www.irw-press.at/prcom/images/messages/2023/70848/GeneTexGlobal_EN_PRcom.001.jpeg
GeneTex Launches PD-L1 Antibody Comprehensively Validated by MS Validated Antibodies GmbH for Immunohistochemistry

IRVINE, CA / ACCESSWIRE / June 6, 2023 / GeneTex, a multinational antibody manufacturing company, is leveraging its recombinant monoclonal antibody production platform to produce

GeneTex lanciert PD-L1-Antikörper, der von MS Validated Antibodies GmbH für Immunhistochemie umfassend validiert wurde: https://www.irw-press.at/prcom/images/messages/2023/70848/GeneTexGlobal_DE_PRcom.001.jpeg
GeneTex lanciert PD-L1-Antikörper, der von MS Validated Antibodies GmbH für Immunhistochemie umfassend validiert wurde

Irvine, CA / Accesswire / 6. Juni 2023 / GeneTex, ein multinationales Unternehmen zur Antikörperherstellung, nutzt seine Produktionsplattform für rekombinante monoklonale Antikörper, um

GeneTex lanciert PD-L1-Antikörper, der von MS Validated Antibodies GmbH für Immunhistochemie umfassend validiert wurde: https://www.irw-press.at/prcom/images/messages/2023/70848/GeneTexGlobal_DE_PRcom.001.jpeg
GeneTex lanciert PD-L1-Antikörper, der von MS Validated Antibodies GmbH für Immunhistochemie umfassend validiert wurde

Irvine, CA / Accesswire / 6. Juni 2023 / GeneTex, ein multinationales Unternehmen zur Antikörperherstellung, nutzt seine Produktionsplattform für rekombinante monoklonale Antikörper, um

GeneTex lanciert PD-L1-Antikörper, der von MS Validated Antibodies GmbH für Immunhistochemie umfassend validiert wurde: https://www.irw-press.at/prcom/images/messages/2023/70848/GeneTexGlobal_DE_PRcom.001.jpeg
GeneTex lanciert PD-L1-Antikörper, der von MS Validated Antibodies GmbH für Immunhistochemie umfassend validiert wurde

Irvine, CA / Accesswire / 6. Juni 2023 / GeneTex, ein multinationales Unternehmen zur Antikörperherstellung, nutzt seine Produktionsplattform für rekombinante monoklonale Antikörper, um

GeneTex lanciert PD-L1-Antikörper, der von MS Validated Antibodies GmbH für Immunhistochemie umfassend validiert wurde: https://www.irw-press.at/prcom/images/messages/2023/70848/GeneTexGlobal_DE_PRcom.001.jpeg
GeneTex lanciert PD-L1-Antikörper, der von MS Validated Antibodies GmbH für Immunhistochemie umfassend validiert wurde

Irvine, CA / Accesswire / 6. Juni 2023 / GeneTex, ein multinationales Unternehmen zur Antikörperherstellung, nutzt seine Produktionsplattform für rekombinante monoklonale Antikörper, um

GeneTex Launches PD-L1 Antibody Comprehensively Validated by MS Validated Antibodies GmbH for Immunohistochemistry: https://www.irw-press.at/prcom/images/messages/2023/70848/GeneTexGlobal_EN_PRcom.001.jpeg
GeneTex Launches PD-L1 Antibody Comprehensively Validated by MS Validated Antibodies GmbH for Immunohistochemistry

IRVINE, CA / ACCESSWIRE / June 6, 2023 / GeneTex, a multinational antibody manufacturing company, is leveraging its recombinant monoclonal antibody production platform to produce

GeneTex Launches PD-L1 Antibody Comprehensively Validated by MS Validated Antibodies GmbH for Immunohistochemistry: https://www.irw-press.at/prcom/images/messages/2023/70848/GeneTexGlobal_EN_PRcom.001.jpeg
GeneTex Launches PD-L1 Antibody Comprehensively Validated by MS Validated Antibodies GmbH for Immunohistochemistry

IRVINE, CA / ACCESSWIRE / June 6, 2023 / GeneTex, a multinational antibody manufacturing company, is leveraging its recombinant monoclonal antibody production platform to produce

GeneTex Launches PD-L1 Antibody Comprehensively Validated by MS Validated Antibodies GmbH for Immunohistochemistry: https://www.irw-press.at/prcom/images/messages/2023/70848/GeneTexGlobal_EN_PRcom.001.jpeg
GeneTex Launches PD-L1 Antibody Comprehensively Validated by MS Validated Antibodies GmbH for Immunohistochemistry

IRVINE, CA / ACCESSWIRE / June 6, 2023 / GeneTex, a multinational antibody manufacturing company, is leveraging its recombinant monoclonal antibody production platform to produce

Dynatrace Stock Surges On AI, 'Mandatory' Network Monitoring: https://www.marketbeat.com/logos/articles/med_20230606065924_dynatrace-stock-surges-on-ai-mandatory-network-mon.jpg
Dynatrace Stock Surges On AI, 'Mandatory' Network Monitoring

Dynatrace Inc. (NYSE: DT) has been a strong performer recently, benefiting from the market's optimism about the company’s AI technologies, as well as its network monitoring services.

A glimpse of

Dynatrace Stock Surges On AI, 'Mandatory' Network Monitoring: https://www.marketbeat.com/logos/articles/med_20230606065924_dynatrace-stock-surges-on-ai-mandatory-network-mon.jpg
Dynatrace Stock Surges On AI, 'Mandatory' Network Monitoring

Dynatrace Inc. (NYSE: DT) has been a strong performer recently, benefiting from the market's optimism about the company’s AI technologies, as well as its network monitoring services.

A glimpse of

Analysts Raise Targets For Builders FirstSource Again: https://www.marketbeat.com/logos/articles/med_20230606065107_analysts-raise-targets-for-builders-firstsource-ag.jpg
Analysts Raise Targets For Builders FirstSource Again

It is a rare and celebratory occasion when a stock rises by more than 65% during twelve months. Still, it is even more extraordinary when the same stock has an additional 28.5% rally upon

The Most Upgraded Stocks In May Are Moving Higher: https://www.marketbeat.com/logos/articles/med_20230605094142_chart-panw-crm-652023.png
The Most Upgraded Stocks In May Are Moving Higher

According to Marketbeat.com’s analyst tracking tools, the most upgraded stocks in May are NVIDIA (NASDAQ: NVDA), Palo Alto Networks (NASDAQ: PANW), and Salesforce.com (NASDAQ: CRM). The single

The Most Upgraded Stocks In May Are Moving Higher: https://www.marketbeat.com/logos/articles/med_20230605094142_chart-panw-crm-652023.png
The Most Upgraded Stocks In May Are Moving Higher

According to Marketbeat.com’s analyst tracking tools, the most upgraded stocks in May are NVIDIA (NASDAQ: NVDA), Palo Alto Networks (NASDAQ: PANW), and Salesforce.com (NASDAQ: CRM). The single

The Most Upgraded Stocks In May Are Moving Higher: https://www.marketbeat.com/logos/articles/med_20230605094142_chart-panw-crm-652023.png
The Most Upgraded Stocks In May Are Moving Higher

According to Marketbeat.com’s analyst tracking tools, the most upgraded stocks in May are NVIDIA (NASDAQ: NVDA), Palo Alto Networks (NASDAQ: PANW), and Salesforce.com (NASDAQ: CRM). The single

Risk-On In Small-Caps After iShares Russell 2000 ETF Breaks Out: https://www.marketbeat.com/logos/articles/med_20230604121708_iwm-chart.jpg
Risk-On In Small-Caps After iShares Russell 2000 ETF Breaks Out

The iShares Russell 2000 ETF (NYSE: IWM) has displayed relative weakness and lagged the overall market over the previous year. However, it notably broke that trend last week and finally showed

Risk-On In Small-Caps After iShares Russell 2000 ETF Breaks Out: https://www.marketbeat.com/logos/articles/med_20230604121708_iwm-chart.jpg
Risk-On In Small-Caps After iShares Russell 2000 ETF Breaks Out

The iShares Russell 2000 ETF (NYSE: IWM) has displayed relative weakness and lagged the overall market over the previous year. However, it notably broke that trend last week and finally showed

Risk-On In Small-Caps After iShares Russell 2000 ETF Breaks Out: https://www.marketbeat.com/logos/articles/med_20230604121708_iwm-chart.jpg
Risk-On In Small-Caps After iShares Russell 2000 ETF Breaks Out

The iShares Russell 2000 ETF (NYSE: IWM) has displayed relative weakness and lagged the overall market over the previous year. However, it notably broke that trend last week and finally showed

Risk-On In Small-Caps After iShares Russell 2000 ETF Breaks Out: https://www.marketbeat.com/logos/articles/med_20230604121708_iwm-chart.jpg
Risk-On In Small-Caps After iShares Russell 2000 ETF Breaks Out

The iShares Russell 2000 ETF (NYSE: IWM) has displayed relative weakness and lagged the overall market over the previous year. However, it notably broke that trend last week and finally showed

Here’s Why Disney’s MCU is Sinking in Quicksand: https://www.marketbeat.com/logos/articles/med_20230604133550_chart-dis2.jpg
Here’s Why Disney’s MCU is Sinking in Quicksand

Media and entertainment giant The Walt Disney Company (NYSE: DIS) has seen a continued decline in its Disney+ subscribers and live-action box office debuts. Disney+ lost four million subscribers